
Loading

Loading
We use strictly necessary cookies to run this site, and analytics cookies to understand how it's used. See our Privacy Policy for details.

VANCOUVER, BC, Oct.
Summary
2, 2026 /CNW/ — Light AI Inc. (“Light AI” or the “Company”) (Cboe CA: ALGO; (FSE: 0HC) (OTCQB: OHCFF) today announced that it will keep its QuickScan™ Strep A software-as-a-medical-device (“SaMD”) in controlled product development and continue its hold on related clinical activities.
This is a brief wire summary, the full story (linked below) has the complete details.
KazaSec's take
AI-related security incidents are a genuinely new category, prompt injection, model manipulation, and data leakage through an LLM integration don't map cleanly onto traditional application security testing, and are worth assessing deliberately rather than assuming existing controls already cover them.
Coverage details
Relevant from KazaSec
More security news
We help organizations find and fix the gaps before they make headlines.